- Home
- HURA vs GUNN Comparison
HURA vs GUNN Comparison
Compare HURA & GUNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HURA | GUNN |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.0M | 142.6M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HURA | GUNN |
|---|---|---|
| Price | $1.72 | $7.89 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.04 | N/A |
| AVG Volume (30 Days) | ★ 366.5K | 74.2K |
| Earning Date | 11-17-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $593.30 |
| Revenue Next Year | N/A | $10.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $7.82 |
| 52 Week High | $3.43 | $9.16 |
Technical Indicators
Market Signals| Indicator | HURA | GUNN |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | N/A |
| Support Level | $1.27 | N/A |
| Resistance Level | $2.22 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 0.86 | 0.00 |
Price Performance
Historical Comparison HURA
GUNN
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.